Figures S1-S3 1 H NMRs of relevant compounds Figure S4 Three-fold dilution topoisomerase II inhibition assay of compounds 13 and 16
Three-fold dilution topoisomerase II inhibition assay of compounds 13 and 16
Figure S5-S10 One dose NCI 60 cancer cell growth data (10µM) Figure S11 -S13 Five dose NCI 60 cancer cell growth data with GI50, TGI and LC50 data for compound 11 Figure S14 -S16 Five dose NCI 60 cancer cell growth data with GI50, TGI and LC50 data for compound 13 Figure S17 : COMPARE Analysis data for compound 13 in direct comparison with SCH1473759 (NSC761691), an Aurora kinase inhibitor. 
